Patient case studies are beginning to emerge regarding
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare type of autoimmune disorder. In an autoimmune disease, the body attacks its own tissues. In CIDP, the body attacks the myelin sheaths. These are the fatty coverings on the fibers that insulate and protect the nerves.
ANerv_20140205_v2_001
Experts think that CIDP is related to the more commonly known disease Guillain-Barré syndrome (GBS). GBS is generally considered a short-term (acute) disease. CIDP is considered a long-term (chronic) disease. CIDP is less common than GBS.
CIDP is usually classified as follows:
Progressive. The disease continues to worsen over time.
Recurrent. Episodes of symptoms stop and start.
Monophasic. This means one bout of the disease lasts 1 to 3 years and doesn’t recur.
What causes CIDP?
CIDP occurs when the body’s immune system attacks the myelin sheaths around nerve cells. But exactly what triggers this isn’t clear. Unlike GBS, there usually isn’t an infection preceding CIDP. There doesn’t seem to be a genetic link to CIDP.
While neurological reporting during the pandemic focused on reports after positive SARS-CoV-2 tests, more and more neurological complications are being reported after a COVID injection. While we certainly cannot highlight all 13,500 neurological reports, we can provide this excellent paper that describes cases of three patients with neurological manifestations after a SARS-CoV-2 jab (including boosters). In another paper, the authors investigated hospital admissions for neurological complications and found increased incidences of Guillain-Barre syndrome, Bell’s palsy, adverse cardiac events, and stroke.
Source: Eye On The Evidence – Neurological Side Effects of the COVID-19 Jab In Work – The Tenpenny Report